A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

Recruiting

Phase 1

ELVN-001A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

Sponsor:

Enliven Therapeutics

Code:

NCT05304377

Conditions

Chronic Myeloid Leukemia

Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

Cml

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ELVN-001

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-07. This information was provided to ClinicalTrials.gov by Enliven Therapeutics on 2026-04-01.